Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AstraZeneca
Eastern Cooperative Oncology Group
Rigshospitalet, Denmark
Inhibrx Biosciences, Inc
AstraZeneca
University of Kentucky
AstraZeneca
AstraZeneca
Columbia University
Grupo Español de Investigación en Cáncer de Ovario